Pfizer Lookout For A Partner For Drug Manufacturing

Major pharmaceutical company Pfizer is on a lookout for potential contract manufacturing options. This is because Pfizer is ensuring that the Covid-19 antiviral drug can be accessed across the low- and middle-income countries including India. Through this potential manufacturing options, the company wants that there must be an easy access to Covid-19 antiviral drug among the countries. Nevertheless, the company has not specified any names with which the company is in touch for manufacturing the antiviral drug.

A Pfizer company spokesperson spoke with ET that the company has begun investing $1 billion, at risk, in the manufacture of its potential Covid-19 oral antiviral drug with the goal of making treatment courses available as quickly as possible, pending authorisation.